Lupin receives FDA approval for SUPRAX Capsules

June 05, 2012 / 12:15 IST

Lupin Ltd has informed BSE regarding a Press Release dated June 05, 2012 titled "Lupin receives FDA approval for SUPRAX (Cefixime) Capsules, 400 mg; NDA Approval to add to growing SUPRAX Franchise"Source : BSE

Read all announcements in Lupin

first published: Jun 5, 2012 12:15 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Lupin receives FDA approval for SUPRAX Capsules

Lupin receives FDA approval for SUPRAX Capsules

LC03